Medtronic plc (MDT) operating KPIs
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic diabetes Portfolio (Consolidated Segment) — U.S. Revenue ($M) ($M)
Medtronic Form 8-K U.S. Revenue Tables
Latest, Q1 FY27
240
Period ended Jul 31, 2026
Change on a year earlier
+10.6%
217 in Q1 FY26
History
47 quarters
Since Q3 FY15
Sources
43
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up diabetes portfolio (consolidated segment) — u.s. revenue ($m)
Cite this data
StockData. (2026). Medtronic Diabetes Portfolio (Consolidated Segment) — U.S. Revenue ($M) ($M), quarterly Q3 FY15–Q1 FY27 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/diab-seg-us-rev
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.